Literature DB >> 17207035

Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.

Richard Wai Wing Lee1, Steven Terence Lindstrom.   

Abstract

BACKGROUND AND
OBJECTIVE: The major cost of managing community-acquired pneumonia (CAP) relates to the duration i.v. antibiotic use and length of hospital stay (LOS). Guidelines on early switch to oral antibiotics and early discharge from hospital may help to achieve a unified approach to managing CAP. The aim of this study was to assess the benefits and safety of these guidelines in an Australian respiratory medicine unit.
METHODS: This prospective study included consecutive patients admitted with a diagnosis of CAP over a 6-month period. Early switch to oral antibiotics and early discharge guidelines were implemented one month prior to the evaluation period. Comparison was made to a retrospective control group admitted before the guidelines were implemented. Data collection included patient demographics, clinical and outcome parameters, duration of i.v. antibiotics and LOS. Thirty-day outcomes on patient safety and satisfaction were collected from the prospective group.
RESULTS: One hundred and twenty-five patients in the prospective group were compared to 100 patients in the controls. Baseline characteristics were similar between the comparison groups. Both the mean duration of i.v. antibiotics used (3.38 +/- 0.22 vs. 3.99 +/- 0.28 days, P = 0.03) and LOS (7.62 +/- 0.60 vs. 8.36 +/- 0.55 days, P = 0.04) were significantly shorter in the prospective group. Thirty-day readmission rate was 6% and patient self-reported overall satisfaction was 93.9% in those who were followed up.
CONCLUSIONS: The use of early switch and early discharge guidelines for CAP reduced the duration of i.v. antibiotics and LOS while maintaining high levels of safety and patient satisfaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207035     DOI: 10.1111/j.1440-1843.2006.00931.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  9 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis.

Authors:  Zoe Athanassa; Gregory Makris; George Dimopoulos; Matthew E Falagas
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Modern Management of Community-Acquired Pneumonia: Is It Cost-Effective and are Outcomes Acceptable?

Authors:  Dominik Mertz; Jennie Johnstone
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

4.  Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.

Authors:  K de With; F Allerberger; S Amann; P Apfalter; H-R Brodt; T Eckmanns; M Fellhauer; H K Geiss; O Janata; R Krause; S Lemmen; E Meyer; H Mittermayer; U Porsche; E Presterl; S Reuter; B Sinha; R Strauß; A Wechsler-Fördös; C Wenisch; W V Kern
Journal:  Infection       Date:  2016-06       Impact factor: 3.553

5.  Novel carbapenem antibiotics for parenteral and oral applications: in vitro and in vivo activities of 2-aryl carbapenems and their pharmacokinetics in laboratory animals.

Authors:  Koichi Fujimoto; Koji Takemoto; Kazuo Hatano; Toru Nakai; Shigeyuki Terashita; Masahiro Matsumoto; Yoshiro Eriguchi; Ken Eguchi; Takeshi Shimizudani; Kimihiko Sato; Katsunori Kanazawa; Makoto Sunagawa; Yutaka Ueda
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

6.  Short- vs long-course antibiotic therapy for pneumonia: a comparison of systematic reviews and guidelines for the SIMI Choosing Wisely Campaign.

Authors:  Ludovico Furlan; Luca Erba; Lucia Trombetta; Roberto Sacco; Giorgio Colombo; Giovanni Casazza; Monica Solbiati; Nicola Montano; Chiara Marta; Rodolfo Sbrojavacca; Francesco Perticone; Gino Roberto Corazza; Giorgio Costantino
Journal:  Intern Emerg Med       Date:  2018-10-08       Impact factor: 3.397

7.  Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study.

Authors:  Giulio DiDiodato; Leslie McArthur; Joseph Beyene; Marek Smieja; Lehana Thabane
Journal:  Trials       Date:  2015-08-14       Impact factor: 2.279

Review 8.  Switch over from intravenous to oral therapy: A concise overview.

Authors:  Jissa Maria Cyriac; Emmanuel James
Journal:  J Pharmacol Pharmacother       Date:  2014-04

9.  Outcomes of early switching from intravenous to oral antibiotics on medical wards.

Authors:  Dominik Mertz; Michael Koller; Patricia Haller; Markus L Lampert; Herbert Plagge; Balthasar Hug; Gian Koch; Manuel Battegay; Ursula Flückiger; Stefano Bassetti
Journal:  J Antimicrob Chemother       Date:  2009-04-28       Impact factor: 5.790

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.